CORC

在结果中检索

CORC

浏览/检索结果: 共175条，第1-10条 帮助

限定条件    
已选(0)清除 条数/页：   排序方式：
Pupil Dilation Reflecting the Characteristics of Attention Networks of Patients Using Image Processing 会议论文
Changchun, China, 2022-02-25
作者:  Zhang, Huangyemin;  Wen, Shirui;  Zhu, Guangpu;  Huang, Kailing;  Hu, Bingliang
收藏  |  浏览/下载：22/0  |  提交时间：2022/05/11
Diamine molecules double lock-link structured graphene oxide sheets for high-performance sodium ions storage 会议论文
作者:  Zhang, Yu-Shan;  Zhang, Bin-Mei;  Hu, Yu-Xia;  Li, Jun;  Lu, Chun
收藏  |  浏览/下载：18/0  |  提交时间：2020/12/18
Long-distance atmospheric moisture dominates water budget in permafrost regions of the Central Qinghai-Tibet plateau 会议论文
作者:  Zhu, Xiaofan;  Wu, Tonghua;  Hu, Guojie;  Wang, Shengjie;  Wu, Xiaodong
收藏  |  浏览/下载：14/0  |  提交时间：2020/12/18
Adaptive Variance Based Label Distribution Learning For Facial Age Estimation 会议论文
online, 2020-08
作者:  Wen Xin;  Li Biying;  Guo Haiyun;  Liu Zhiwei;  Hu Guosheng
收藏  |  浏览/下载：38/0  |  提交时间：2020/10/14
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：48/0  |  提交时间：2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：39/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：40/0  |  提交时间：2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：33/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：31/0  |  提交时间：2019/12/05
Cavitation pressure fluctuation characteristics of a prototype pump-turbine analysed by using CFD (Open Access) 会议论文
作者:  Wen, F.F.;  Cheng, Y.G.;  You, J.F.;  Li, T.C.;  Hu, H.P.
收藏  |  浏览/下载：7/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace